Transcatheter aortic valve replacement has emerged as a viable alternative treatment option for patients with severe aortic stenosis who are considered inoperable or at high surgical risk.
This review summarizes the current role, technological advances, and procedural aspects of TAVR in high-risk or inoperable patients with severe aortic stenosis.
Aortic stenosis is the most common valvular heart disease of old age. Patients with severe aortic stenosis who develop symptoms have a very poor prognosis without valve intervention. Surgical aortic valve replacement has historically been the only treatment option for these patients. However a significant minority are considered inoperable or at high surgical risk and therefore are refused or decline surgery. In recent years, transcatheter aortic valve replacement has emerged as an alternative treatment option in these high-risk patients. The aim of this review is to summarize the current role of transcatheter aortic valve replacement in contemporary clinical practice including recent advances in technological and procedural aspects and then discuss future directions.
Mangieri et al. (Mon,) conducted a review in Severe aortic stenosis. Transcatheter aortic valve replacement was evaluated. Transcatheter aortic valve replacement has emerged as a viable alternative treatment option for patients with severe aortic stenosis who are considered inoperable or at high surgical risk.